Healthy Japanese adult
Conditions
Interventions
5 times amount overdose of plant extract-containing food for 4 weeks
Sponsors
Oneness support CO., LTD
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Healthy men and women aged 20 to 79 years old (2) BMI less than 30 (3) A person who has received a sufficient explanation of the purpose and contents of the study, has the ability to consent, voluntarily participates in a well-understood manner, and consents to the examination
Exclusion criteria
Exclusion criteria: People with a history of liver, kidney, digestive system, heart disease, respiration, endocrine, metabolism, nerve, consciousness disorder, diabetes, seizures, and other diseases that may affect the results of this test, or Person who has a history of surgery. Patients who have been hospitalized for treatment due to stroke, subarachnoid hemorrhage, cerebral infarction, cerebral hemorrhage, brain contusion, head injury. Those who show abnormal liver and kidney function test values. Person who has disease under treatment now. Person with food and drug allergy. Person with anemia symptom. Those who have experienced ill mood or worsened physical condition by blood collection in the past. Those who donated more than 200 mL from the month before the start of the test to the start of the test, or those who have plans for it during the test period. Those who do intense sports and those who are on a diet. Person who has excessive smoking habit. Those who have an irregular diet. Persons who regularly use health food (including antioxidants, supplements with blood flow improvement effect) for the purpose of improving brain function or forgetfulness. Those who are taking medicines (anti-psychotic, anxiety, depressants, Parkinson's disease, epilepsy, blood clotting drugs, etc.) that may affect this study. Persons who can not quit the intake of health food (including food for specified health and functional indication food) or designated quasi-drugs during the test period. Those who are taking medication (including OTC and prescription drugs) continuously. Those who have consumed too much alcohol or who can not drink alcohol from the day before the test until the day. persons who are pregnant or who are planning pregnancy or breastfeeding during the study period. Those who are participating in or planning to participate in other clinical trials at the beginning of this trial, within 4 weeks after the end of the trial. Others who are judged inappropriate by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Physical hand and physical examination Hematology and blood biochemistry Urinalysis Journal | — |
Countries
Japan
Contacts
Public ContactMegumi Takahashi
RYUSENDO CO., LTD. Development Office
Outcome results
None listed